Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Fatal Familial Insomnia Initially Developing Parkinsonism Mimicking Dementia with Lewy Bodies

Fukuoka T, Nakazato Y, Yamamoto M, Miyake A, Mitsufuji T, Yamamoto T.

Intern Med. 2018 Sep 15;57(18):2719-2722. doi: 10.2169/internalmedicine.0573-17. Epub 2018 Apr 27.

The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration

Maïza A, Chantepie S, Vera C, Fifre A, Huynh MB, Stettler O, Ouidja MO, Papy-Garcia D.

FEBS Lett. 2018 Dec;592(23):3806-3818. doi: 10.1002/1873-3468.13082. Epub 2018 Jun 14.

A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia

Knight R, Khondoker M, Magill N, Stewart R, Landau S.

Dement Geriatr Cogn Disord. 2018;45(3-4):131-151. doi: 10.1159/000486546. Epub 2018 May 7.

Stem Cell Therapies for Neurodegenerative Diseases

Sugaya K, Vaidya M.

Adv Exp Med Biol. 2018;1056:61-84. doi: 10.1007/978-3-319-74470-4_5.

HIV Dementia with a Decreased Cardiac (123)I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies

Kurihara M, Sasaki T, Ishiura H, Tsuji S.

Intern Med. 2018 Oct 15;57(20):3007-3010. doi: 10.2169/internalmedicine.0876-18. Epub 2018 May 18.

Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea

Polito CA, Cai ZY, Shi YL, Li XM, Yang R, Shi M, Li QS, Ma SC, Xiang LP, Wang KR, Ye JH, Lu JL, Zheng XQ, Liang YR.

Nutrients. 2018 May 22;10(5):655. doi: 10.3390/nu10050655.

[Epidemiology of Alzheimer's disease and other dementias]

Garre-Olmo J.

Rev Neurol. 2018 Jun 1;66(11):377-386.

Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases

Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y.

Molecules. 2018 May 29;23(6):1297. doi: 10.3390/molecules23061297.

Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences

de Andrade Teles RB, Diniz TC, Costa Pinto TC, de Oliveira Júnior RG, Gama E Silva M, de Lavor ÉM, Fernandes AWC, de Oliveira AP, de Almeida Ribeiro FPR, da Silva AAM, Cavalcante TCF, Quintans Júnior LJ, da Silva Almeida JRG.

Oxid Med Cell Longev. 2018 May 10;2018:7043213. doi: 10.1155/2018/7043213. eCollection 2018.

[Parkinson's disease, Alzheimer's disease and oncological diseases in residential geriatric care : Pain frequency and selected healthcare features in comparison]

Kutschar P, Lex K, Osterbrink J, Lorenzl S.

Schmerz. 2018 Oct;32(5):356-363. doi: 10.1007/s00482-018-0302-x.

Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases

Choi ML, Gandhi S.

FEBS J. 2018 Oct;285(19):3631-3644. doi: 10.1111/febs.14587. Epub 2018 Aug 21.

Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration

Deza-Ponzio R, Herrera ML, Bellini MJ, Virgolini MB, Hereñú CB.

Neurotoxicology. 2018 Sep;68:19-24. doi: 10.1016/j.neuro.2018.06.005. Epub 2018 Jun 21.

Untangling the Tauopathy for Alzheimer's disease and parkinsonism

Chang HY, Sang TK, Chiang AS.

J Biomed Sci. 2018 Jul 10;25(1):54. doi: 10.1186/s12929-018-0457-x.

Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca

Liu AKL, Lim EJ, Ahmed I, Chang RC, Pearce RKB, Gentleman SM.

Neuropathol Appl Neurobiol. 2018 Dec;44(7):647-662. doi: 10.1111/nan.12513. Epub 2018 Aug 13.

Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

Macdonald R, Barnes K, Hastings C, Mortiboys H.

Biochem Soc Trans. 2018 Aug 20;46(4):891-909. doi: 10.1042/BST20170501. Epub 2018 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias